Fundz

Barcelona-based Gate2Brain raises €7 million to advance its brain tumour candidate, marking its largest investment to date with Shilpa Biocare as a strategic partner.

PRIVATEJun 16, 2026

Amount Raised

€7 Million

Round Type

Venture

BarcelonaBiotechnologyHealth CareMedicalTherapeutics

Investors

Shilpa Biocare Pvt Ltd

Description

Gate2Brain, a Spanish BioTech company, has secured a €7 million investment, the largest raised by the company to date. The investment represents a 30.4% equity stake and includes a strategic partnership with Shilpa Biocare Pvt Ltd. This funding will support Gate2Brain's mission to advance their technology platform targeting brain tumours. The company acknowledges the support of its institutional partners and investors in this endeavor.

Quick answer

Gate2Brain raised €7 Million in a funding round, dated June 16, 2026. Investors: Shilpa Biocare Pvt Ltd. Gate2Brain is based in Barcelona, Catalonia, Spain.

How much did Gate2Brain raise?
Gate2Brain raised €7 Million in a funding round on June 16, 2026.
Who invested in Gate2Brain?
Shilpa Biocare Pvt Ltd is named as investors in this round.
What does Gate2Brain do?
Gate2Brain is a Spanish BioTech company developing a therapeutic candidate for aggressive paediatric and adult brain tumours.
Where is Gate2Brain based and how big is it?
Gate2Brain is based in Barcelona, Catalonia, Spain.
Who are the decision-makers at Gate2Brain?
Fundz holds 1 contact at Gate2Brain, including the Ceo/cso. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Gate2Brain that raised within 45 days of this round, from Fundz verified event records.

  • Adjuvia Therapeutics raised $8M (Seed) on July 29, 2026.
  • Scancell Holdings PLC raised $39M (Post-IPO Equity) on July 23, 2026.
  • Georgiamune raised $93M on July 16, 2026.
  • Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
  • Racura Oncology raised $34M (Funding Round) on June 17, 2026.
  • Kordata Dynamics raised an undisclosed amount (Pre-Seed) on May 21, 2026.

Who to call at Gate2Brain, and when

A new round usually means Gate2Brain is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Gate2Brain raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gate2Brain, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gate2Brain. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Gate2Brain

Location

Barcelona, Catalonia, Spain

About

Gate2Brain is a Spanish BioTech company developing a therapeutic candidate for aggressive paediatric and adult brain tumours. Founded in 2020 as a spin-off from IRB Barcelona, the University of Barcelona, and Hospital Sant Joan de Déu Barcelona, the company focuses on addressing high unmet medical needs in central nervous system diseases. Its lead candidate, G2B-002, utilizes a proprietary technology to enhance drug delivery across the blood-brain barrier. Gate2Brain collaborates with strategic partners to accelerate development and expand its technology platform.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Gate2Brain raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMeritxell T., Ceo/cso hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Gate2Brain's next move

See what Strategic adds

Gate2Brain raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.